Topics

TAT 2020 Honorary Award: A recognition in cancer drug development to Lillian Siu

19:00 EST 10 Feb 2020 | AAAS

(European Society for Medical Oncology) The European Society for Medical Oncology is pleased to announce that Lillian L. Siu, Professor at the University of Toronto and Medical Oncologist at the Princess Margaret Cancer Centre, Toronto, will receive the TAT 2020 Honorary Award in recognition of her pivotal contributions in the development of new anticancer drugs, particularly with respect to phase I trials in head and neck malignancies. The award will be presented during the ESMO Targeted Anticancer Therapies Congress, to be held in Paris, France, March 2-4.

Original Article: TAT 2020 Honorary Award: A recognition in cancer drug development to Lillian Siu

NEXT ARTICLE

More From BioPortfolio on "TAT 2020 Honorary Award: A recognition in cancer drug development to Lillian Siu"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...